217 related articles for article (PubMed ID: 36844744)
1. Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer.
Li SY; Yoshida Y; Kubota M; Zhang BS; Matsutani T; Ito M; Yajima S; Yoshida K; Mine S; Machida T; Hayashi A; Takemoto M; Yokote K; Ohno M; Nishi E; Kitamura K; Kamitsukasa I; Takizawa H; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Iwase K; Shimada H; Iwadate Y; Hiwasa T
Front Cardiovasc Med; 2023; 10():1042272. PubMed ID: 36844744
[TBL] [Abstract][Full Text] [Related]
2. Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.
Hiwasa T; Wang H; Goto KI; Mine S; Machida T; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kunimatsu M; Kamitsukasa I; Mori M; Sugimoto K; Uzawa A; Muto M; Kuwabara S; Kobayashi Y; Ohno M; Nishi E; Hattori A; Yamamoto M; Maezawa Y; Kobayashi K; Ishibashi R; Takemoto M; Yokote K; Takizawa H; Kishimoto T; Matsushita K; Kobayashi S; Nomura F; Arasawa T; Kagaya A; Maruyama T; Matsubara H; Tomiita M; Hamanaka S; Imai Y; Nakagawa T; Kato N; Terada J; Matsumura T; Katsumata Y; Naito A; Tanabe N; Sakao S; Tatsumi K; Ito M; Shiratori F; Sumazaki M; Yajima S; Shimada H; Shirouzu M; Yokoyama S; Kudo T; Doi H; Iwase K; Ashino H; Li SY; Kubota M; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Iwadate Y
BMC Med; 2021 Jun; 19(1):131. PubMed ID: 34103026
[TBL] [Abstract][Full Text] [Related]
3. Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer.
Ito M; Hiwasa T; Oshima Y; Yajima S; Suzuki T; Nanami T; Sumazaki M; Shiratori F; Funahashi K; Li SY; Iwadate Y; Yamagata H; Jambaljav B; Takemoto M; Yokote K; Takizawa H; Shimada H
Front Oncol; 2021; 11():708039. PubMed ID: 34504788
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases.
Yoshida Y; Zhang XM; Wang H; Machida T; Mine S; Kobayashi E; Adachi A; Matsutani T; Kamitsukasa I; Wada T; Aotsuka A; Iwase K; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Takizawa H; Kashiwado K; Shin H; Akaogi Y; Shimada J; Nishi E; Ohno M; Takemoto M; Yokote K; Kitamura K; Iwadate Y; Hiwasa T
Heliyon; 2020 Aug; 6(8):e04661. PubMed ID: 32904265
[TBL] [Abstract][Full Text] [Related]
5. JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases.
Zhang BS; Zhang XM; Ito M; Yajima S; Yoshida K; Ohno M; Nishi E; Wang H; Li SY; Kubota M; Yoshida Y; Matsutani T; Mine S; Machida T; Takemoto M; Yamagata H; Hayashi A; Yokote K; Kobayashi Y; Takizawa H; Kuroda H; Shimada H; Iwadate Y; Hiwasa T
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732153
[TBL] [Abstract][Full Text] [Related]
6. Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis.
Li SY; Yoshida Y; Kobayashi E; Kubota M; Matsutani T; Mine S; Machida T; Maezawa Y; Takemoto M; Yokote K; Kobayashi Y; Takizawa H; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kobayashi S; Matsushita K; Nomura F; Matsubara H; Sumazaki M; Ito M; Yajima S; Shimada H; Iwase K; Ashino H; Wang H; Goto K; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Iwadate Y; Hiwasa T
Sci Rep; 2021 Jun; 11(1):13450. PubMed ID: 34188129
[TBL] [Abstract][Full Text] [Related]
7. Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.
Li SY; Yoshida Y; Kobayashi E; Adachi A; Hirono S; Matsutani T; Mine S; Machida T; Ohno M; Nishi E; Maezawa Y; Takemoto M; Yokote K; Kitamura K; Sumazaki M; Ito M; Shimada H; Takizawa H; Kashiwado K; Tomiyoshi G; Shinmen N; Nakamura R; Kuroda H; Zhang XM; Wang H; Goto K; Iwadate Y; Hiwasa T
Int J Mol Med; 2020 Oct; 46(4):1274-1288. PubMed ID: 32945427
[TBL] [Abstract][Full Text] [Related]
8. Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus.
Namiki T; Takemoto M; Hayashi A; Yamagata H; Ishikawa T; Yokote K; Li SY; Kubota M; Zhang BS; Yoshida Y; Matsutani T; Mine S; Machida T; Kobayashi Y; Terada J; Naito A; Tatsumi K; Takizawa H; Nakamura R; Kuroda H; Iwadate Y; Hiwasa T
BMC Endocr Disord; 2023 Oct; 23(1):239. PubMed ID: 37904164
[TBL] [Abstract][Full Text] [Related]
9. The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma.
Ito M; Yajima S; Suzuki T; Oshima Y; Nanami T; Sumazaki M; Shiratori F; Wang H; Hu L; Takizawa H; Li SY; Iwadate Y; Hiwasa T; Shimada H
Med Int (Lond); 2023; 3(2):11. PubMed ID: 36875818
[TBL] [Abstract][Full Text] [Related]
10. Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases.
Sumazaki M; Shimada H; Ito M; Shiratori F; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Iwadate Y; Mine S; Machida T; Kamitsukasa I; Mori M; Sugimoto K; Uzawa A; Kuwabara S; Kobayashi Y; Ohno M; Nishi E; Maezawa Y; Takemoto M; Yokote K; Takizawa H; Kashiwado K; Shin H; Kishimoto T; Matsushita K; Kobayashi S; Nakamura R; Shinmen N; Kuroda H; Zhang XM; Wang H; Goto KI; Hiwasa T
Cancer Sci; 2020 Dec; 111(12):4453-4464. PubMed ID: 32939876
[TBL] [Abstract][Full Text] [Related]
11. Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction.
Wang H; Lu H; Zhang XM; Goto KI; Kobayashi E; Yoshida Y; Adachi A; Matsutani T; Iwadate Y; Mine S; Machida T; Sata M; Yamagishi K; Iso H; Sawada N; Tsugane S; Kamitsukasa I; Wada T; Aotsuka A; Sugimoto K; Takizawa H; Kashiwado K; Shin H; Tomiyoshi G; Nakamura R; Shinmen N; Kuroda H; Xu A; Hiwasa T
BMC Neurol; 2021 Jul; 21(1):274. PubMed ID: 34243715
[TBL] [Abstract][Full Text] [Related]
12. Serum anti‑TSTD2 antibody as a biomarker for atherosclerosis‑induced ischemic stroke and chronic kidney disease.
Kubota M; Zhang BS; Li SY; Yoshida Y; Wang H; Adachi A; Matsutani T; Mine S; Machida T; Kamitsukasa I; Wada T; Aotsuka A; Kitamura K; Takizawa H; Kuroda H; Iwadate Y; Hiwasa T
Med Int (Lond); 2023; 3(1):4. PubMed ID: 36699658
[TBL] [Abstract][Full Text] [Related]
13. Identification of serum anti-striatin 4 antibodies as a common marker for esophageal cancer and other solid cancers.
Ito M; Hiwasa T; Oshima Y; Yajima S; Suzuki T; Nanami T; Sumazaki M; Shiratori F; Funahashi K; Takizawa H; Kashiwado K; Tochigi N; Shimada H
Mol Clin Oncol; 2021 Nov; 15(5):237. PubMed ID: 34650804
[TBL] [Abstract][Full Text] [Related]
14. Demethylation and Overexpression of CSF2 are Involved in Immune Response, Chemotherapy Resistance, and Poor Prognosis in Colorectal Cancer.
Xu Z; Zhang Y; Xu M; Zheng X; Lin M; Pan J; Ye C; Deng Y; Jiang C; Lin Y; Lu X; Chi P
Onco Targets Ther; 2019; 12():11255-11269. PubMed ID: 31908491
[TBL] [Abstract][Full Text] [Related]
15. Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis.
Hu L; Liu J; Shimada H; Ito M; Sugimoto K; Hiwasa T; Zhou Q; Li J; Shen S; Wang H
Front Oncol; 2022; 12():870086. PubMed ID: 35656505
[TBL] [Abstract][Full Text] [Related]
16. Analysis of patients with colorectal cancer shows a specific increase in serum anti-ING1 autoantibody levels.
Arasawa T; Hiwasa T; Kagaya A; Maruyama T; Uesato M; Kano M; Kobayashi S; Takizawa H; Iwase K; Nomura F; Matsushita K; Matsubara H
BMC Cancer; 2023 Apr; 23(1):356. PubMed ID: 37072777
[TBL] [Abstract][Full Text] [Related]
17. Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma.
Ito M; Hiwasa T; Yajima S; Suzuki T; Oshima Y; Nanami T; Sumazaki M; Shiratori F; Li SY; Iwadate Y; Sugimoto K; Mori M; Kuwabara S; Takizawa H; Shimada H
Esophagus; 2022 Oct; 19(4):617-625. PubMed ID: 35780443
[TBL] [Abstract][Full Text] [Related]
18. Association of high proprotein convertase subtilisin/kexin type 9 antibody level with poor prognosis in patients with diabetes: a prospective study.
Yamagata H; Hayashi A; Yoshida Y; Koshizaka M; Onishi S; Yoshida T; Hiwasa T; Takemoto M
Sci Rep; 2023 Apr; 13(1):5391. PubMed ID: 37012310
[TBL] [Abstract][Full Text] [Related]
19. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer.
Kunizaki M; Sawai T; Takeshita H; Tominaga T; Hidaka S; To K; Miyazaki T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2016 Aug; 36(8):4171-5. PubMed ID: 27466527
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Pre- and Postoperative Anti-p53 Antibody Levels in Colorectal Cancer Patients: A Retrospective Study.
Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Ootani K; Yasuda K; Murono K; Watanabe T
Oncology; 2017; 92(1):31-38. PubMed ID: 27794579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
